Primary Care

Tuberculosis

Questions discussed in this category

How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?

4 Answers available

For which patients or under which circumstances do you recommend a 9-month over a 6-month course of isoniazid for treatment of LTBI?

1 Answer available

What is your preferred method for latent tuberculosis screening prior to outpatient hemodialysis initiation for a patient with new dialysis requirements?

3 Answers available

What is your approach to prescribing RIPE for 6 month vs rifapentine/moxifloxacin for 4 months in the treatment of drug sensitive TB in the US?

1 Answer available

What is your approach to a positive PPD or IGRA in a patient with well-controlled HIV without significant TB risk factors?

3 Answers available

How do you approach a positive Quantiferon/PPD test result in a patient for whom testing is sent without a clinical indication and who does not have a risk factor for TB exposure nor TB reactivation?

Do you routinely offer latent TB treatment in these cases?

2 Answers available

For how long do you recommend treatment for latent tuberculosis prior to initiation of anti-TNF therapy?

6 Answers available

Do you routinely monitor imaging or pulmonary function in patients with pulmonary TB after the completion of therapy?

1 Answer available

How would you manage methotrexate therapy in an active rheumatoid arthritis patient undergoing treatment for latent TB with rifampin?

Do you stop methotrexate or adjust the dose?

1 Answer available

Should tuberculosis screening be performed before beginning methotrexate for treatment of rheumatoid arthritis?

1 Answer available

Papers discussed in this category

Arthritis Care Res (Hoboken), 2016 Jan

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Alimentary pharmacology & therapeutics, 2022 May 20

Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.

American journal of respiratory and critical care medicine, 2019 Nov 15

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Related Topics in Primary Care